Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Reata Pharmaceuticals closes $22.6mm Series D round
16 Aug 2006
Reata Pharmaceuticals (developing therapeutics to treat cancer and inflammatory and neurodegenerative diseases) has raised $22.6mm with the closing of its Series D venture round led by Cardinal Investment. New backers included Novo AS, which will now have a representative on the company's board.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?